NeuScience technology uses high throughput cell assays and AI to discover new treatments for solid tumor cancers. Our biological assay combines patient-derived cells and clinical biomarkers to ensure high predictive accuracy, while our cutting-edge deep learning platform offers single-cell sensitivity.
| Website | http://www.neuscience.co |
| Employees | 4 (1 on RocketReach) |
| Founded | 2018 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+7 more
(view full list)
|
| Industry | Biotechnology, Drug Discovery, Biotechnology Research, Deep Learning, AI, High-Content Screening, Pharmaceuticals, Machine Learning, Computer Vision, Computational Biology, Cancer, Oncology, Metastasis |
| Keywords | Cancer Treatment, Cancer Research, Clinical Biomarkers, Drug Discovery, Oncology, Biotechnology, Drug Development, High Throughput Screening, Biomarkers, Pharmaceutical, Therapeutics, Precision Medicine, Clinical Trials, Predictive Modeling, Artificial Intelligence, Machine Learning |
Looking for a particular NeuScience employee's phone or email?
NeuScience Questions
Guillermo Vela is the CEO and Co-Founder of NeuScience.
1 people are employed at NeuScience.
Top NeuScience Employees
-
Guillermo Vela
CEO and Co-Founder at NeuScience
United States5+3
Related Companies
G2Crowd Trusted
300K+
Plugin Users
